FLUCONAZOLE I. V.
November 10, 2017ENOVA 40/60
November 10, 2017
| TRANZ INJECTION |
Tranexamic Acid Inj. 500 mg |
|
| Composition : |
Tranexamic acid 500 mg/5 ml |
| Indications : |
In patients with hemophilia for short-term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
|
| Contraindications : |
In patients with acquired defective color vision, subarachnoid hemorrhage, active intravascular clotting and hypersensitivity to tranexamic acid or any of the ingredients.
|
| Adverse Effects : |
Gastrointestinal disturbances (nausea, vomiting, and diarrhea) may occur but disappear when the dosage is reduced. Allergic dermatitis, giddiness, and hypotension have been reported occasionally. |
| Dosage : |
The recommended standard dose is 5-10 ml by slow intravenous injection at a rate of 1ml/minute, two to three times daily. |
